Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Journal of Molecular Medicine (Berlin, Germany)|February 15, 2023
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivoSameer H Patel, Magdalena Bachmann, Stephanie Kadow, et al.
Biological Chemistry|June 17, 2018
Pathological manifestations of Farber disease in a new mouse modelNadine Beckmann, Stephanie Kadow, Fabian Schumacher, et al.
Journal of Personalized Medicine|September 28, 2021
Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?Pia Proske, Laura Distelmaier, Carmen Aramayo-Singelmann, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|December 6, 2019
Inhibition of PI-3-K and AKT Amplifies Kv1.3 Inhibitor-Induced Death of Human T Leukemia CellsTim Bergermann, Lukas Born, Fiona Ferguson, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 10, 2025
Global patterns of amyloid typing: results of a survey by the International Society of Amyloidosis (ISA)Hironobu Naiki, Mona Johnson, Kaylee Walters, et al.
Hemasphere|June 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid DiseasesAlexander Carpinteiro, Christoph Kimmich, Despina Trajanova, et al.
The Journal of Biological Chemistry|June 26, 2022
Ceramide levels in blood plasma correlate with major depressive disorder severity and its neutralization abrogates depressive behavior in miceFabian Schumacher, Michael J Edwards, Christiane Mühle, et al.
The Journal of Biological Chemistry|September 12, 2020
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2Michael J Edwards, Katrin Anne Becker, Barbara Gripp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2026
Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES TrialsAshutosh D Wechalekar, Angela Dispenzieri, Vaishali Sanchorawala, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|April 6, 2026
Transthyretin stabilizer therapy increases naturally-occurring antibodies in ATTR cardiomyopathyStephan Settelmeier, Daniel Agranovski, Maximilian Steinhardt, et al.
Pageof 9